Connecticut Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
Connecticut Wealth Management's ABBV Position: Q2 2026 in Review
Connecticut Wealth Management increased its AbbVie (ABBV) stake by 4.1% in Q2 2026, buying an estimated $71.6K and bringing the position to 8,519 shares worth $2.14M. The position accounts for 0.08% of the portfolio, ranked #101.
Connecticut Wealth Management first reported a position in ABBV in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.17M in Q1 2025. 2,162 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Connecticut Wealth Management held 8,519 shares of AbbVie worth $2.14M as of Q2 2026.
- Connecticut Wealth Management bought 333 AbbVie shares in Q2 2026, an estimated $71.6K.
- AbbVie made up 0.08% of Connecticut Wealth Management's portfolio in Q2 2026, its #101 holding.
- Connecticut Wealth Management first reported a position in AbbVie in Q3 2020 and has held it in 17 quarters since.
- Connecticut Wealth Management's AbbVie position peaked at $2.17M in Q1 2025.
- 2,162 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.